IL127684A0 - Composition for appetite suppression - Google Patents

Composition for appetite suppression

Info

Publication number
IL127684A0
IL127684A0 IL12768497A IL12768497A IL127684A0 IL 127684 A0 IL127684 A0 IL 127684A0 IL 12768497 A IL12768497 A IL 12768497A IL 12768497 A IL12768497 A IL 12768497A IL 127684 A0 IL127684 A0 IL 127684A0
Authority
IL
Israel
Prior art keywords
composition
appetite suppression
appetite
suppression
Prior art date
Application number
IL12768497A
Original Assignee
Nicada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicada Inc filed Critical Nicada Inc
Publication of IL127684A0 publication Critical patent/IL127684A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12768497A 1996-07-17 1997-07-16 Composition for appetite suppression IL127684A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68353596A 1996-07-17 1996-07-17
PCT/US1997/012408 WO1998002165A1 (en) 1996-07-17 1997-07-16 Appetite suppression

Publications (1)

Publication Number Publication Date
IL127684A0 true IL127684A0 (en) 1999-10-28

Family

ID=24744444

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12768497A IL127684A0 (en) 1996-07-17 1997-07-16 Composition for appetite suppression

Country Status (7)

Country Link
EP (1) EP0912181A1 (en)
JP (1) JP2000515139A (en)
KR (1) KR20000023819A (en)
AU (1) AU3666497A (en)
CA (1) CA2260892A1 (en)
IL (1) IL127684A0 (en)
WO (1) WO1998002165A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1094809A2 (en) * 1998-06-26 2001-05-02 Elaine A. Delack Use of histamine h2 mimicking substances for the treatment of multiple sclerosis
US7232830B2 (en) 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
US6485710B2 (en) * 2000-12-27 2002-11-26 Arthur Zuckerman Appetite suppressant toothpaste
US6610277B2 (en) * 2000-12-27 2003-08-26 Arthur Zuckerman Appetite suppressant toothpaste
US7048941B2 (en) 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
AU2003242695B2 (en) 2002-07-01 2007-12-06 Unilever Plc Satiety inducing composition
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
US7674482B2 (en) * 2002-08-27 2010-03-09 Targeted Medical Pharma Inc. Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
EP1534314B1 (en) * 2002-09-04 2014-10-22 DSM IP Assets B.V. A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction
WO2004023647A1 (en) 2002-09-06 2004-03-18 Telefonaktiebolaget Lm Ericsson Composite power amplifier
CA2518658A1 (en) * 2003-03-14 2004-09-30 Pro-Health, Inc. Composition and method for appetite and craving suppression and mood enhancement
KR20070034528A (en) * 2004-05-27 2007-03-28 캄피나 네덜란드 홀딩 베.붸. Use of protein hydrolysates for the manufacture of pharmaceuticals for the prevention and / or treatment of DPP-IV mediated diseases
WO2006053217A1 (en) * 2004-11-12 2006-05-18 Mccleary, Edward Larry Weight loss composition and method
ES2381118T3 (en) 2004-12-23 2012-05-23 Campina Nederland Holding B.V. Protein hydrolyzate enriched in DPP-IV inhibition peptides and their use
GB0520917D0 (en) * 2005-10-14 2005-11-23 Zumbe Albert Chocolate based appetite suppressant
EP1954299B1 (en) 2005-11-30 2016-01-13 Campina Nederland Holding B.V. Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1
JP2008094787A (en) * 2006-10-13 2008-04-24 Paq Kk Sympathetic nerve stimulant using peanut-treated material
GB0719545D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719542D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract
GB0719544D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and use thereof
ES2325435B1 (en) * 2008-01-02 2010-06-17 Armando Jose Yañez Soler COMPOSITION BASED ON COCOA AND SPIRULIN.
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
JP4593639B2 (en) 2008-03-04 2010-12-08 株式会社マルハニチロ食品 Peptide-containing feeding regulator
JP4691571B2 (en) 2008-03-04 2011-06-01 株式会社マルハニチロ食品 Feeding regulator
AU2011254726B2 (en) 2010-05-19 2014-03-06 Upfield Europe B.V. Theobromine for increasing HDL-cholesterol
ES2545187T3 (en) * 2010-10-05 2015-09-09 Dsm Ip Assets B.V. Use of lysozyme hydrolyzate containing tryptophan to reduce appetite during or after stressful situations
JP5886657B2 (en) * 2012-02-29 2016-03-16 株式会社ファンケル Formulation containing powder derived from wheat bran
US20140129484A1 (en) * 2012-11-02 2014-05-08 Dsm Ip Assets B.V. Method of marketing protein hydrolysate for high energy sensation
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867539A (en) * 1973-04-27 1975-02-18 Us Health Method of producing anorexia as a treatment for obesity
DE2743702A1 (en) * 1977-06-03 1978-12-14 Pharmaceutical Export Promotio PREPARATION OF ANIMAL AND SLIMMING PROCESS AND METHOD FOR PRODUCING IT
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
US4897380A (en) * 1985-08-30 1990-01-30 Pollack Robert L Method and composition for relieving dietary-related disorders
US5019594A (en) * 1989-11-28 1991-05-28 Interneuron Pharmaceuticals, Inc. Method for decreasing appetite
FR2657013B1 (en) * 1990-01-18 1992-05-15 Medgenix Group Sa DIETETIC COMPOSITION BASED ON POLYPEPTIDES AND AMINO ACIDS.

Also Published As

Publication number Publication date
JP2000515139A (en) 2000-11-14
KR20000023819A (en) 2000-04-25
CA2260892A1 (en) 1998-01-22
AU3666497A (en) 1998-02-09
WO1998002165A1 (en) 1998-01-22
EP0912181A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
IL127684A0 (en) Composition for appetite suppression
CY2506B1 (en) Composition
GB9600426D0 (en) Compositions
PL332118A1 (en) Remineralisable compositions
GB9624874D0 (en) Composition
IL128718A0 (en) Naaldase compositions
IL130330A0 (en) Endo-ectoparasiticidal compositions
GB9601398D0 (en) Composition
GB9612595D0 (en) Composition
GB9605247D0 (en) Composition
EP0884044A4 (en) Hairtreatment composition
GB9619074D0 (en) Composition
GB9624540D0 (en) Compositions
GB9600604D0 (en) Composition
GB9623562D0 (en) Sachet-packaged compositions
GB9620504D0 (en) Compositions
GB9602266D0 (en) Composition
HRP970569A2 (en) Fharmaceutical compositions
GB9610966D0 (en) Composition
GB9620503D0 (en) Compositions
GB9611365D0 (en) Compositions
GB9604585D0 (en) Composition
GB9600545D0 (en) Compositions
GB9619464D0 (en) Compositions
GB9607185D0 (en) Compositions